West was the first CEO for Geron, which he founded in 1990. He was also CEO of Advanced Cell Technology and is now CEO of BioTime. Nature Biotechnology talked to him about his initial love for physics, scoring the first funding for Geron and the future of regenerative medicine. http://www.nature.com/nbt/podcast/index.html
Rights and permissions
About this article
Cite this article
First Rounders: Michael West. Nat Biotechnol 32, 313 (2014). https://doi.org/10.1038/nbt0414-313
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0414-313